Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 30.9B | 25.7B | 25.5B | 24.5B |
Cost of revenue | 22.9B | 18.4B | 17.8B | 17.4B |
Gross profit | 8.0B | 7.3B | 7.7B | 7.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.9B | 5.5B | 5.4B | 5.2B |
Other operating expenses | — | — | — | — |
Operating income | 1.5B | 1.2B | 1.6B | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 90M | 105M | 110M | 106M |
Other income expense | 29M | 28M | 20M | 29M |
Pretax income | 1.4B | 1.1B | 1.5B | 1.2B |
Tax provision | 303M | 237M | 353M | 277M |
Net income | 1.1B | 854M | 1.2B | 942M |
Basic EPS | — | 1.9 | 2.6 | 2.0 |
Diluted EPS | — | 1.9 | 2.6 | 2.0 |
Basic average shares | — | 460.1M | 462.5M | 462.2M |
Diluted average shares | — | 461.5M | 463.5M | 463.9M |
EBITDA | 2.3B | 2.0B | 2.4B | 2.0B |
Net income from continuing op. | 1.1B | 854M | 1.2B | 942M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |